|
|
Article: Discovery of HM74A, target for nicotinic acid, may lead to discovery of drug.
- Article from:
- Heart Disease Weekly
- Article date:
- May 18, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 MAY 18 - (NewsRx.com & NewsRx.net) -- Discovery of HM74A, target for nicotinic acid, may lead to discovery of superior drug molecules to treat dyslipidemia.
"Nicotinic acid has been used clinically for over 40 years in the treatment of dyslipidemia producing a desirable normalization of a range of cardiovascular risk factors, including a marked elevation of high density lipoprotein and a reduction in mortality.
"The precise mechanism of action of nicotinic acid is unknown, although it is believed that activation of a G[subscript]i-G protein-coupled receptor may contribute.
"Utilizing available information on the tissue distribution of ...